Correlation Between Cypress Development and Er Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cypress Development and Er Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cypress Development and Er Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cypress Development Corp and Er Therapeutics, you can compare the effects of market volatilities on Cypress Development and Er Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cypress Development with a short position of Er Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cypress Development and Er Therapeutics.

Diversification Opportunities for Cypress Development and Er Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cypress and PNGM is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cypress Development Corp and Er Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Er Therapeutics and Cypress Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cypress Development Corp are associated (or correlated) with Er Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Er Therapeutics has no effect on the direction of Cypress Development i.e., Cypress Development and Er Therapeutics go up and down completely randomly.

Pair Corralation between Cypress Development and Er Therapeutics

If you would invest  0.01  in Er Therapeutics on September 5, 2024 and sell it today you would earn a total of  0.00  from holding Er Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Cypress Development Corp  vs.  Er Therapeutics

 Performance 
       Timeline  
Cypress Development Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cypress Development Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Cypress Development reported solid returns over the last few months and may actually be approaching a breakup point.
Er Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Er Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Er Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Cypress Development and Er Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cypress Development and Er Therapeutics

The main advantage of trading using opposite Cypress Development and Er Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cypress Development position performs unexpectedly, Er Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Er Therapeutics will offset losses from the drop in Er Therapeutics' long position.
The idea behind Cypress Development Corp and Er Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Directory
Find actively traded commodities issued by global exchanges